These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3190460)

  • 1. Neurofilament degradation in the nervous system of rats intoxicated with acrylamide, related compounds or 2,5-hexanedione.
    Tanii H; Hayashi M; Hashimoto K
    Arch Toxicol; 1988 Aug; 62(1):70-5. PubMed ID: 3190460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of modification and degradation of neurofilament proteins in rats subchronically treated with allyl chloride, acrylamide, or 2,5-hexanedione.
    Nagano M; Yamamoto H; Harada K; Miyamoto E; Futatsuka M
    Environ Res; 1993 Nov; 63(2):229-40. PubMed ID: 8243417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neurotoxicity related to selective disruption of microtubules and intermediate filaments.
    Sager PR; Matheson DW
    Toxicology; 1988 May; 49(2-3):479-92. PubMed ID: 3376145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acrylamide and 2,5-hexanedione on brain mitochondrial respiration.
    Medrano CJ; LoPachin RM
    Neurotoxicology; 1989; 10(2):249-55. PubMed ID: 2616066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. IV. In vitro analysis of transport following acrylamide and 2,5-hexanedione.
    Sickles DW
    Toxicol Lett; 1992 Jul; 61(2-3):199-204. PubMed ID: 1641866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal effects of acrylamide and 2,5-hexanedione: selective aggregation of vimentin filaments.
    Sager PR
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):141-55. PubMed ID: 2464860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrylamide and 2,5-hexanedione neuropathies: abnormal bidirectional transport rate in distal axons.
    Sahenk Z; Mendell JR
    Brain Res; 1981 Aug; 219(2):397-405. PubMed ID: 6167334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione.
    Sickles DW
    Toxicol Appl Pharmacol; 1991 May; 108(3):390-6. PubMed ID: 2020966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The etiology of toxic peripheral neuropathies: in vitro effects of acrylamide and 2,5-hexanedione on brain enolase and other glycolytic enzymes.
    Howland RD; Vyas IL; Lowndes HE; Argentieri TM
    Brain Res; 1980 Nov; 202(1):131-42. PubMed ID: 6448665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication.
    Monaco S; Jacob J; Jenich H; Patton A; Autilio-Gambetti L; Gambetti P
    Brain Res; 1989 Jul; 491(2):328-34. PubMed ID: 2475210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport.
    Monaco S; Wongmongkolrit T; Shearson CM; Patton A; Schaetzle B; Autilio-Gambetti L; Gambetti P; Sayre LM
    Brain Res; 1990 Jun; 519(1-2):73-81. PubMed ID: 2118823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
    Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
    Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of toxicities of acrylamide and 2,5-hexanedione in hens and rats on 3-week dosing regimens.
    Jortner BS; Ehrich M
    J Toxicol Environ Health; 1993 Aug; 39(4):417-28. PubMed ID: 8345530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament protein crosslinking in gamma-diketone neuropathy: in vitro and in vivo studies using the seaworm myxicola infundibulum.
    St Clair MB; Anthony DC; Wikstrand CJ; Graham DG
    Neurotoxicology; 1989; 10(4):743-56. PubMed ID: 2562540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical studies of acrylamide-associated neuropathology.
    Hashimoto K; Kurosaka Y; Tanii H; Hayashi M
    Toxicology; 1988 Apr; 49(1):65-9. PubMed ID: 3287693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the neutral proteinase activities of central and peripheral nervous systems of acrylamide-, carbon disulfide-, or 2,5-hexanedione-treated rats.
    Gupta RP; Abou-Donia MB
    Mol Chem Neuropathol; 1996 Sep; 29(1):53-66. PubMed ID: 8887940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity of acrylamide and 2,5-hexanedione in rats evaluated using a functional observational battery and pathological examination.
    Shell L; Rozum M; Jortner BS; Ehrich M
    Neurotoxicol Teratol; 1992; 14(4):273-83. PubMed ID: 1522832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of acrylamide and related compounds in rats. Effects on rotarod performance, morphology of nerves and neurotubulin.
    Tanii H; Hashimoto K
    Arch Toxicol; 1983 Nov; 54(3):203-13. PubMed ID: 6661030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,5-Hexanedione induced decrease in cytoskeletal proteins of rat sciatic-tibial nerve.
    Zhang T; Zhao X; Zhu Z; Yu L; Han X; Zhang C; Xie K
    Neurochem Res; 2005 Feb; 30(2):177-83. PubMed ID: 15895820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.
    DeCaprio AP; Briggs RG; Jackowski SJ; Kim JC
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):75-85. PubMed ID: 3341029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.